
|Articles|August 22, 2011
Are the Most Heavily Marketed Drugs the Least Beneficial?
Author(s)Jan Henderson, PhD
In a perfect world, doctors would not prescribe – and patients would not take – drugs that do more harm than good.
Advertisement
In a perfect world, doctors would not prescribe – and patients would not take – drugs that do more harm than good. But it’s complicated. The benefits and harms of drugs are determined in randomized, controlled clinical trials. For many reasons, the outcomes of such trials may not provide doctors with the information they need to decide who should take what.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
Centanafadine Gains FDA Approval for ADHD Across Age Groups
2
Primary Care Lens: What HR 1 Means for Medicaid and Primary Care
3
FDA Approves mRNA-1010 (mFLUSIVA) as mRNA Flu Vaccine for Adults 50 and Older
4
New CVD Risk Model Flags Heart Disease Earlier in Reproductive-Age Women
5
















































































































































